BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 19519840)

  • 1. Distribution of emm types among group A streptococcal isolates from Serbia.
    Mijac V; Ranin L; Marković M; Heeg C; Reinert RR; Opavski N
    Clin Microbiol Infect; 2010 Mar; 16(3):295-8. PubMed ID: 19519840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types.
    Michos AG; Bakoula CG; Braoudaki M; Koutouzi FI; Roma ES; Pangalis A; Nikolopoulou G; Kirikou E; Syriopoulou VP
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):295-9. PubMed ID: 19395219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of emm types 1 and 12 from invasive Streptococcus pyogenes disease in Greece--results of enhanced surveillance.
    Stathi A; Papaparaskevas J; Zachariadou L; Pangalis A; Legakis NJ; Tseleni-Kotsovili A; ; Tassios PT
    Clin Microbiol Infect; 2008 Aug; 14(8):808-12. PubMed ID: 18727807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of emm types and superantigens of Streptococcus pyogenes isolates from children during two sampling periods.
    Ma Y; Yang Y; Huang M; Wang Y; Chen Y; Deng L; Yu S; Deng Q; Zhang H; Wang C; Liu L; Shen X
    Epidemiol Infect; 2009 Oct; 137(10):1414-9. PubMed ID: 19243651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease of erythromycin resistance in group A streptococci by change of emm distribution.
    Koh EH; Kim S; Lee NY
    Jpn J Infect Dis; 2008 Jul; 61(4):261-3. PubMed ID: 18653965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology of group A streptococcus causing scarlet fever in northern Taiwan, 2001-2002.
    Chen YY; Huang CT; Yao SM; Chang YC; Shen PW; Chou CY; Li SY
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):289-95. PubMed ID: 17532590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outbreak of invasive group A streptococcal disease among children attending a day-care center.
    Aguero J; Ortega-Mendi M; Eliecer Cano M; Gonzalez de Aledo A; Calvo J; Viloria L; Mellado P; Pelayo T; Fernandez-Rodriguez A; Martinez-Martinez L
    Pediatr Infect Dis J; 2008 Jul; 27(7):602-4. PubMed ID: 18520444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns.
    Tewodros W; Kronvall G
    J Clin Microbiol; 2005 Sep; 43(9):4369-76. PubMed ID: 16145079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Characteristics of Erythromycin-Resistant Streptococcus pyogenes Strains Isolated from Children Patients in Tunis, Tunisia.
    Ksia S; Smaoui H; Hraoui M; Bouafsoun A; Boutiba-Ben Boubaker I; Kechrid A
    Microb Drug Resist; 2017 Jul; 23(5):633-639. PubMed ID: 27991848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological markers of Streptococcus pyogenes strains in Tunisia.
    Hraoui M; Boutiba-Ben Boubaker I; Doloy A; Samir E; Ben Redjeb S; Bouvet A
    Clin Microbiol Infect; 2011 Jan; 17(1):63-8. PubMed ID: 20132259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates.
    Shulman ST; Tanz RR; Dale JB; Beall B; Kabat W; Kabat K; Cederlund E; Patel D; Rippe J; Li Z; Sakota V;
    Clin Infect Dis; 2009 Jul; 49(1):78-84. PubMed ID: 19480575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007.
    Imöhl M; Reinert RR; Ocklenburg C; van der Linden M
    FEMS Immunol Med Microbiol; 2010 Apr; 58(3):389-96. PubMed ID: 20146737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group A streptococcal infections: trend and strain emm typing in an area of central Italy, 1985-2002.
    Mencarelli M; Corbisiero R; Padula MG; Galgani I; Stolzuoli L; Cellesi C
    Epidemiol Infect; 2005 Dec; 133(6):1107-11. PubMed ID: 16274508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles.
    Meisal R; Andreasson IK; Høiby EA; Aaberge IS; Michaelsen TE; Caugant DA
    J Clin Microbiol; 2010 Mar; 48(3):842-51. PubMed ID: 20042624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrolide, lincosamide and tetracycline susceptibility and emm characterisation of invasive Streptococcus pyogenes isolates in Israel.
    Nir-Paz R; Block C; Shasha D; Korenman Z; Gorodnitzky Z; Jaffe J; Ron M; Michael-Gayego A; Cohen-Poradosu R; Shapiro M; Moses AE
    Int J Antimicrob Agents; 2006 Oct; 28(4):313-9. PubMed ID: 16973336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations.
    Smeesters PR; Vergison A; Junior DC; Van Melderen L
    Int J Antimicrob Agents; 2009 Jul; 34(1):44-9. PubMed ID: 19269141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superantigen gene profile diversity among clinical group A streptococcal isolates.
    Maripuu L; Eriksson A; Norgren M
    FEMS Immunol Med Microbiol; 2008 Nov; 54(2):236-44. PubMed ID: 18754783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study.
    Ekelund K; Skinhøj P; Madsen J; Konradsen HB
    J Clin Microbiol; 2005 Apr; 43(4):1789-96. PubMed ID: 15815000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptococcus pyogenes emm and T types within a decade, 1996-2005: implications for epidemiology and future vaccines.
    Nir-Paz R; Korenman Z; Ron M; Michael-Gayego A; Cohen-Poradosu R; Valinsky L; Beall B; Moses AE
    Epidemiol Infect; 2010 Jan; 138(1):53-60. PubMed ID: 19480723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of Streptococcus pyogenes isolates resistant to erythromycin and tetracycline in Spain (1994-2006).
    Rubio-López V; Valdezate S; Alvarez D; Villalón P; Medina MJ; Salcedo C; Sáez-Nieto JA
    BMC Microbiol; 2012 Sep; 12():215. PubMed ID: 22998619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.